191 related articles for article (PubMed ID: 15239554)
1. Intraoperative blood management in joint replacement surgery.
Tenholder M; Cushner FD
Orthopedics; 2004 Jun; 27(6 Suppl):s663-8. PubMed ID: 15239554
[TBL] [Abstract][Full Text] [Related]
2. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
3. Strategies for minimizing blood loss in orthopedic surgery.
Tobias JD
Semin Hematol; 2004 Jan; 41(1 Suppl 1):145-56. PubMed ID: 14872436
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement.
Zohar E; Fredman B; Ellis M; Luban I; Stern A; Jedeikin R
Anesth Analg; 1999 Dec; 89(6):1382-7. PubMed ID: 10589612
[TBL] [Abstract][Full Text] [Related]
5. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.
Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS
Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
8. Methods of reducing allogeneic blood demand in orthopedic surgery.
Dragan S; Kulej M; Krawczyk A; Wall A; Płocieniak K; Urbański W
Ortop Traumatol Rehabil; 2012; 14(3):199-214. PubMed ID: 22764333
[TBL] [Abstract][Full Text] [Related]
9. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
10. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
12. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients.
Bernet F; Carrel T; Marbet G; Skarvan K; Stulz P
J Card Surg; 1999; 14(2):92-7. PubMed ID: 10709819
[TBL] [Abstract][Full Text] [Related]
13. [Blood conservation approaches in orthopedic surgery].
Rosencher N; Bellamy L; Chabbouh T; Arnaout L; Ozier Y
Transfus Clin Biol; 2008 Nov; 15(5):294-302. PubMed ID: 18930421
[TBL] [Abstract][Full Text] [Related]
14. [PERIOPERATIVE BLOOD MANAGEMENT STRATEGIES FOR JOINT ARTHROPLASTY].
Li L; Wu H; Wu Y; Fu P; Ding Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jun; 29(6):772-6. PubMed ID: 26466485
[TBL] [Abstract][Full Text] [Related]
15. Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding.
Nuttall GA; Oliver WC; Ereth MH; Santrach PJ; Bryant SC; Orszulak TA; Schaff HV
Anesthesiology; 2000 Mar; 92(3):674-82. PubMed ID: 10719945
[TBL] [Abstract][Full Text] [Related]
16. Reducing perioperative blood loss and allogeneic blood transfusion in patients undergoing major spine surgery.
Tse EY; Cheung WY; Ng KF; Luk KD
J Bone Joint Surg Am; 2011 Jul; 93(13):1268-77. PubMed ID: 21776581
[TBL] [Abstract][Full Text] [Related]
17. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
Gill JB; Rosenstein A
J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
[TBL] [Abstract][Full Text] [Related]
18. Antifibrinolytics.
Schmarts
Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
[No Abstract] [Full Text] [Related]
19. Bleeding in liver surgery: prevention and treatment.
Alkozai EM; Lisman T; Porte RJ
Clin Liver Dis; 2009 Feb; 13(1):145-154. PubMed ID: 19150318
[TBL] [Abstract][Full Text] [Related]
20. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin.
Engel JM; Hohaus T; Ruwoldt R; Menges T; Jürgensen I; Hempelmann G
Anesth Analg; 2001 Mar; 92(3):775-80. PubMed ID: 11226117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
